Director Faith L. Charles filed a Form 4 with the SEC on November 16, 2026, disclosing a purchase of 15,000 shares of Abeona Therapeutics Inc. common stock on November 13, 2026.
Key Highlights
- Reporting person: Faith L. Charles, identified as a Director of Abeona Therapeutics Inc. (NASDAQ:ABEO)
- Transaction: Purchase (transaction code P) of 15,000 shares of common stock on November 13, 2026
- Price paid: $2.2899 per share
- Resulting ownership: 191,407 shares of common stock held directly following the transaction
- Filing date: November 16, 2026, filed by one reporting person
Director Charles Acquires Additional Abeona Therapeutics Common Stock
According to the Form 4 filing, Faith L. Charles, a director of Abeona Therapeutics Inc., acquired 15,000 shares of the company's common stock on November 13, 2026, at a price of $2.2899 per share. The transaction was coded as a purchase (code "P") in Table I of the filing, which covers non-derivative securities acquired, disposed of, or beneficially owned.
Following the reported transaction, the filing discloses that Charles directly held 191,407 shares of Abeona Therapeutics common stock. The ownership form is listed as direct. No derivative securities transactions were reported in Table II of the filing.
The filing was signed by Faith L. Charles and dated November 16, 2026. The address listed for the reporting person is 6555 Carnegie Ave., 4th Floor, Cleveland, Ohio 44103. No amendment date is indicated, and no Rule 10b5-1 plan checkbox was marked in connection with this transaction.
What Was Disclosed
Faith L. Charles, a director of Abeona Therapeutics Inc. (NASDAQ:ABEO), disclosed the purchase of 15,000 shares of common stock at $2.2899 per share on November 13, 2026, bringing her directly held total to 191,407 shares.



Please wait processing your request...